Diamyd Medical’s associated company Cellaviva launches service for private family saving of stem cells

Diamyd Medical (Nasdaq Stockholm First North, Ticker: DMYD B) announced today that the Company’s associated company Cellaviva AB on September 1 launches its service in which expecting parents in Sweden can save stem cells from their newborn child. Stem cells from the baby’s umbilical cord are saved and stored for at least 20 years in Cellaviva’s biobank. See today’s press release from Cellaviva, http://www.mynewsdesk.com/se/ cellaviva-ab.Diamyd Medical is with its share holding of approximately 39% one of the principal owners of Cellaviva.The reason for Diamyd Medical to be one of the